These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 11259470)

  • 21. Examining Determinants of Radiotherapy Access: Do Cost and Radiotherapy Inconvenience Affect Uptake of Breast-conserving Treatment for Early Breast Cancer?
    Lam J; Cook T; Foster S; Poon R; Milross C; Sundaresan P
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):465-71. PubMed ID: 26009548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.
    Huang EH; Strom EA; Perkins GH; Oh JL; Chen AM; Meric-Bernstam F; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):352-7. PubMed ID: 16887286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A population-based study on variations in the use of adjuvant radiotherapy in breast cancer patients].
    Nagel G; Röhrig B; Hoyer H; Füller J; Katenkamp D
    Strahlenther Onkol; 2002 Nov; 178(11):589-96. PubMed ID: 12426669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical contraindications are not a major factor in the underutilization of breast conserving therapy.
    Morrow M; Bucci C; Rademaker A
    J Am Coll Surg; 1998 Mar; 186(3):269-74. PubMed ID: 9510257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.
    Pierce LJ; Phillips KA; Griffith KA; Buys S; Gaffney DK; Moran MS; Haffty BG; Ben-David M; Kaufman B; Garber JE; Merajver SD; Balmaña J; Meirovitz A; Domchek SM
    Breast Cancer Res Treat; 2010 Jun; 121(2):389-98. PubMed ID: 20411323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival.
    Morris AD; Morris RD; Wilson JF; White J; Steinberg S; Okunieff P; Arriagada R; Lê MG; Blichert-Toft M; van Dongen JA
    Cancer J Sci Am; 1997; 3(1):6-12. PubMed ID: 9072310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients.
    Laurberg T; Lyngholm CD; Christiansen P; Alsner J; Overgaard J
    Radiother Oncol; 2016 Jul; 120(1):98-106. PubMed ID: 27289261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
    van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
    Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years.
    van der Sangen MJ; van de Wiel FM; Poortmans PM; Tjan-Heijnen VC; Nieuwenhuijzen GA; Roumen RM; Ernst MF; Tutein Nolthenius-Puylaert MC; Voogd AC
    Breast Cancer Res Treat; 2011 May; 127(1):207-15. PubMed ID: 20703938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Out-of-Pocket Cost Modeling of Adjuvant Antiestrogen and Radiation Therapy After Lumpectomy for Early-Stage Breast Cancer Across Medicaid and Medicare Plans.
    Wu VS; Khlopin M; Chadha M; Smith-Graziani DJ; Jagsi R; McClelland S
    Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1379-1385. PubMed ID: 38432284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
    World J Surg Oncol; 2017 Jul; 15(1):118. PubMed ID: 28673296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.
    Boughey JC; Peintinger F; Meric-Bernstam F; Perry AC; Hunt KK; Babiera GV; Singletary SE; Bedrosian I; Lucci A; Buzdar AU; Pusztai L; Kuerer HM
    Ann Surg; 2006 Sep; 244(3):464-70. PubMed ID: 16926572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
    Lagendijk M; van Maaren MC; Saadatmand S; Strobbe LJA; Poortmans PMP; Koppert LB; Tilanus-Linthorst MMA; Siesling S
    Int J Cancer; 2018 Jan; 142(1):165-175. PubMed ID: 28884470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Conservative therapy of I and II stage breast cancer--successful alternative to modified radical mastectomy].
    Parvanova VM; Pandova VV; Garanina ZM
    Vopr Onkol; 2001; 47(1):45-8. PubMed ID: 11317534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local-regional control in breast cancer patients with a possible genetic predisposition.
    Freedman LM; Buchholz TA; Thames HD; Strom EA; McNeese MD; Hortobagyi GN; Singletary SE; Heaton KM; Hunt KK
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):951-7. PubMed ID: 11072150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 10-Year Survival after Breast-Conserving Surgery Compared with Mastectomy in Louisiana Women with Early-Stage Breast Cancer: A Population-Based Study.
    Chu QD; Hsieh MC; Lyons JM; Wu XC
    J Am Coll Surg; 2021 Apr; 232(4):607-621. PubMed ID: 33301909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life of Lithuanian women with early stage breast cancer.
    Bulotiene G; Veseliunas J; Ostapenko V
    BMC Public Health; 2007 Jun; 7():124. PubMed ID: 17594500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total Mastectomy or Breast Conservation Therapy? How Radiation Oncologist Accessibility Determines Treatment Choice and Quality: A SEER Data-base Analysis.
    Churilla TM; Donnelly PE; Leatherman ER; Adonizio CS; Peters CA
    Breast J; 2015; 21(5):473-80. PubMed ID: 26133235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.